Evaluating a Workbook to Promote Autistic Wellbeing
Evaluating the Use of a Guided Self-help Workbook to Promote Wellbeing for Autistic Adults: A Mixed-methods Multiple Single-case Study
The goal of this clinical trial is to examine the feasibility and acceptability of a brief guided self-help wellbeing intervention for autistic adults accessing UK secondary mental health services. The study also aims to begin to evaluate whether use of the workbook is associated with any changes in wellbeing. The main questions it aims to answer are:
- Is it feasible to recruit and retain autistic adults to participate in the study?
- Do participants find the workbook acceptable and relevant?
- Are there measurable improvements in wellbeing following workbook use?
- What changes, if any, do participants recommend for future versions of the intervention?
Participants will:
- Take part in 4-6 sessions of 30-60 minutes using the guided self-help workbook with the support of a trained National Health Service support worker, assistant psychologist, or mental health professional
- Complete wellbeing questionnaires before, during, and after using the workbook
- Complete brief daily wellbeing ratings throughout the study
- Take part in a 1:1 semi-structured interview of up to an hour to discuss their experience of the workbook
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Autism is a lifelong neurodevelopmental difference that affects how people communicate, experience the world, and relate to others. In the UK, more than 1% of people are estimated to be autistic, with rates of diagnosis rapidly increasing. Many autistic adults experience mental health challenges such as anxiety, depression, and suicidal thoughts. Some may experience 'autistic burnout', a state of deep exhaustion and loss of coping ability. These difficulties can result from long-term stress, 'masking' (hiding autistic traits to fit in), and lack of understanding or support.
In the UK National Health Service, post-diagnostic support for autistic adults is limited, often consisting only of information or signposting. While existing psychological therapies can help with anxiety and depression, they are not always designed with the needs of autistic people in mind. This highlights a clear need for preventative, accessible, and autism-specific wellbeing support, especially within the National Health Service, where demand is high and resources are limited.
This study aims to explore whether a new guided self-help wellbeing workbook designed specifically for autistic adults is feasible and acceptable, and to get an initial impression of its helpfulness in improving wellbeing. It focuses on helping people to understand autism and manage their energy levels using 'energy accounting' (Toudal & Attwood, 2024), and to plan for wellbeing using personalised strategies. The aim is to help autistic adults improve self-understanding, communicate their needs, and enhance wellbeing in everyday life.
The study will have three phases (baseline: a 1-2 week period prior to completing the workbook; intervention: a 4-6 week period during completion of the workbook; follow-up: a 3-4 week period following workbook completion). Participants will be asked to complete standardised questionnaires at the beginning and end of each phase. Brief daily wellbeing ratings will be collected throughout all three phases. Finally, an interview of up to an hour will be conducted with participants at the end of the follow-up phase.
There are six primary indicators which will be compared against pre-specified progression criteria. The primary outcomes are 1) ease of recruitment to the study; 2) participant retention in the intervention; 3) participant retention in the study; 4) intervention acceptability; 5) outcome measure completion; 6) whether there is a preliminary indicator of efficacy on the primary outcome measure (wellbeing). Progression criteria will be used to help decide whether the research should progress to more powered intervention studies in future.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Kirsten Mann
- Número de teléfono: +44 (0) 333 011 7101
- Correo electrónico: k.mann2949@canterbury.ac.uk
Copia de seguridad de contactos de estudio
- Nombre: Fergal Jones
- Número de teléfono: +44 (0) 1227 927110
- Correo electrónico: fergal.jones@canterbury.ac.uk
Ubicaciones de estudio
-
-
-
Maidstone, Reino Unido, ME16 9PH
- Reclutamiento
- Kent and Medway Mental Health NHS Trust
-
Contacto:
- Dan Brown
- Número de teléfono: +44 (0) 1622 725000
- Correo electrónico: dan.brown9@nhs.net
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- A pre-existing diagnosis of autism OR on a waiting list for autism assessment OR self-identified as autistic and scoring above cut-off on the autism quotient (AQ-50) screening questionnaire.
- Aged 18 years or over and able to give informed consent to participate.
- Under the care of a community-based mental health team in Kent and Medway Mental Health NHS Trust and not due for discharge during the study period.
- Have already completed assessment processes (including risk assessment) during intake by the clinical team and a management plan is in place.
- The named clinician assesses that the individual is in sufficiently stable condition to participate in the study, and is likely to remain engaged in the intervention.
- Proficiency in reading and writing English.
- If on medication for mental health, the dose is stable (minimum of 3 months) with no planned changes during the study.
Exclusion Criteria:
- Presence of a moderate to severe learning disability that would limit independent engagement with self-help materials.
- Engaged in another psychological therapy or psychologically-informed intervention, or due to begin another during the study.
- Current acute mental health crisis or elevated risk to self/others requiring intensive intervention (assessed via clinical team judgement).
- Insufficient capacity to engage with the study protocol or complete measures (as determined by the care team).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Guided self-help workbook for autistic adults
Within-subjects comparison
|
The workbook's components are: psycho-education and energy accounting (Toudal & Attwood, 2024) - including sensory awareness - and planning for wellbeing.
It will be delivered over four to six sessions of between 30-60 minutes each with a trained National Health Service support worker, assistant psychologist, or mental health professional.
Sessions would be conducted in-person, via telephone, or via video.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of participants recruited to the study
Periodo de tiempo: 6 months following start of recruitment
|
The number of participants recruited over 6 months will be compared against the following progression criterion to assess the feasibility of recruitment: Green: 8-10; Amber: 6-7; Red: <5
|
6 months following start of recruitment
|
|
Proportion of participants who complete the guided self-help intervention
Periodo de tiempo: Weeks 2-8
|
The proportion of participants who complete the guided self-help intervention will be compared against the following progression criterion to assess retention in the intervention: Green: ≥75%; Amber: ≥50%; Red: <50%
|
Weeks 2-8
|
|
Proportion of participants who remain in the study
Periodo de tiempo: Weeks 0-12
|
The proportion of study participants who remain in the study will be compared against the following progression criterion to assess retention in the study: Green: ≥75%; Amber: ≥50%; Red: <50%
|
Weeks 0-12
|
|
Guided self-help intervention acceptability
Periodo de tiempo: Weeks 11-12
|
Response to Likert type questions and thematic analysis of qualitative data will be compared against the following progression criterion to assess retention in the study: Green: the majority of participants report the intervention is acceptable as it is or with minor adjustments; Amber: there are inconsistent reports of acceptability or the intervention requires bigger adjustments; Red: the majority of participants report the intervention is unacceptable or requires adjustments which cannot be completed
|
Weeks 11-12
|
|
Completion rate of outcome measures
Periodo de tiempo: Weeks 0-12
|
The rate of the outcome measures completion will be compared against the following progression criterion to assess the feasibility of outcome measurement: Green: ≥75%; Amber ≥50%; Red: <50%
|
Weeks 0-12
|
|
Proportion of participants showing reliable improvement on the ReQoL-20 from baseline (weeks 0-1) to post-intervention (weeks 7-8)
Periodo de tiempo: Baseline (weeks 0-1) and post-intervention (weeks 7-8)
|
The ReQoL-20 contains 20 items measuring quality of life, with higher scores indicating greater quality of life. The proportion of participants showing reliable improvement on the ReQoL-20 from baseline (weeks 0-1) to post-intervention (weeks 7-8) will be compared against the following progression criterion to provide a preliminary indicator of effectiveness: Green: ≥75%; Amber: ≥50%; Red: <50% |
Baseline (weeks 0-1) and post-intervention (weeks 7-8)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Proportion of participants showing reliable improvement on the ReQoL-20 from baseline (weeks 0-1) to follow-up (weeks 11-12)
Periodo de tiempo: Baseline (weeks 0-1) and follow-up (weeks 11-12)
|
The ReQoL-20 contains 20 items measuring quality of life, with higher scores indicating greater quality of life. The proportion of participants showing reliable improvement on the ReQoL-20 from baseline (weeks 0-1) to follow-up (weeks 11-12) will be compared against the following progression criterion to provide a preliminary indicator of effectiveness: Green: ≥75%; Amber: ≥50%; Red: <50% |
Baseline (weeks 0-1) and follow-up (weeks 11-12)
|
|
Proportion of participants showing reliable improvement on the DIALOG from baseline (weeks 0-1) to post-intervention (weeks 7-8)
Periodo de tiempo: Baseline (weeks 0-1) and post-intervention (weeks 7-8)
|
The DIALOG scale contains 11 items measuring quality of life and treatment satisfaction, with higher scores indicating greater satisfaction. The proportion of participants showing reliable improvement on the DIALOG from baseline (weeks 0-1) to post-intervention (weeks 7-8) will be compared against the following progression criterion to provide a preliminary indicator of effectiveness: Green: ≥75%; Amber: ≥50%; Red: <50% |
Baseline (weeks 0-1) and post-intervention (weeks 7-8)
|
|
Proportion of participants showing reliable improvement on the DIALOG from baseline (weeks 0-1) to follow-up (weeks 11-12)
Periodo de tiempo: Baseline (weeks 0-1) and follow-up (weeks 11 to 12)
|
The DIALOG scale contains 11 items measuring quality of life and treatment satisfaction, with higher scores indicating greater satisfaction. The proportion of participants showing reliable improvement on the DIALOG from baseline (weeks 0-1) to follow-up (weeks 11-12) will be compared against the following progression criterion to provide a preliminary indicator of effectiveness: Green: ≥75%; Amber: ≥50%; Red: <50% |
Baseline (weeks 0-1) and follow-up (weeks 11 to 12)
|
|
Change in average level of daily ratings from baseline (weeks 0-1) to post-intervention (weeks 7-8)
Periodo de tiempo: Baseline (weeks 0-1) to post-intervention (weeks 7-8)
|
Brief daily wellbeing ratings (e.g.
'rate your wellbeing on a scale of 0-10') will be collected throughout all phases (baseline, intervention, follow-up) to provide additional time-linked data to evaluate intervention efficacy
|
Baseline (weeks 0-1) to post-intervention (weeks 7-8)
|
|
Change in average level of daily ratings from baseline (weeks 0-1) to follow-up (weeks 11-12)
Periodo de tiempo: Baseline (weeks 0-1) to follow-up (weeks 11-12)
|
Brief daily wellbeing ratings (e.g.
'rate your wellbeing on a scale of 0-10') will be collected throughout all phases (baseline, intervention, follow-up) to provide additional time-linked data to evaluate intervention efficacy
|
Baseline (weeks 0-1) to follow-up (weeks 11-12)
|
|
Qualitative data from follow-up interviews with participants
Periodo de tiempo: Weeks 11-12
|
An interview of up to an hour will be conducted with participants at the end of the follow-up phase to explore their experiences of using the workbook
|
Weeks 11-12
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Toudal, M., & Attwood, T. (2024). Energy accounting: Stress management and mental health monitoring for autism and related conditions. Jessica Kingsley Publishers.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- DClinPsychol24KMann
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .